Page last updated: 2024-11-01

nimodipine and Active Hyperemia

nimodipine has been researched along with Active Hyperemia in 2 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hawkes, MA1
Hlavnicka, AA1
Wainsztein, NA1
Rhee, RY1
Gloviczki, P1
Cambria, RA1
Lowell, RC1
Okazaki, H1

Other Studies

2 other studies available for nimodipine and Active Hyperemia

ArticleYear
Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone.
    Neurocritical care, 2020, Volume: 32, Issue:1

    Topics: Adult; Angiography, Digital Subtraction; Aphasia, Broca; Brain Edema; Cerebral Hemorrhage; Computed

2020
The effects of nimodipine on ischemic injury of the spinal cord during thoracic aortic cross-clamping.
    International angiology : a journal of the International Union of Angiology, 1996, Volume: 15, Issue:2

    Topics: Animals; Aorta, Thoracic; Calcium Channel Blockers; Constriction; Dogs; Hyperemia; Laser-Doppler Flo

1996